http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022160812-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85b13a1a8d32ebe3d1aca65cbd31dd3a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2020-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74d9f54d21ab70a36d3cd499d1f51527 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3755685ac24dc886c721b6baf7a9110 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30a024183016c9df81b018e33c338e4d |
| publicationDate | 2022-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2022160812-A1 |
| titleOfInvention | A pharmaceutically active substance |
| abstract | The invention relates to a pharmaceutically active substance comprising at least one peptide portion having the amino acid sequences m-v-v-y-f-r (first peptide portion), characterised in that the pharmaceutically active substance comprises at least additional one amino acid and/or peptide portion at the N-terminal end and/or at the C-terminal end of the first peptide portion (second peptide portion and/or third peptide portion) being directly bound to the peptide portion having the amino acid sequences m-v-v-y-f-r (first peptide portion). The invention further relates to a pharmaceutical composition and a drug for the treatment of cancer. |
| priorityDate | 2019-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1043.